Published in Biomed Res Int on July 03, 2014
Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem (2003) 4.55
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int (2009) 4.02
The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol (1998) 3.65
Ras plasma membrane signalling platforms. Biochem J (2005) 2.15
Obstructive nephropathy: insights from genetically engineered animals. Kidney Int (2005) 1.97
Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int (2005) 1.83
Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol (2009) 1.76
Ras alters epithelial-mesenchymal transition in response to TGFbeta by reducing actin fibers and cell-matrix adhesion. Cell Cycle (2009) 1.70
Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol (2004) 1.55
Potential antitumor effects of statins (Review). Int J Oncol (2003) 1.54
Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension (2000) 1.21
Ras biochemistry and farnesyl transferase inhibitors: a literature survey. Anticancer Drugs (2001) 1.16
Angiotensin II controls p21ras activity via pp60c-src. J Biol Chem (1996) 1.10
Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol (2003) 1.09
Unilateral ureteral obstruction: beyond obstruction. Int Urol Nephrol (2013) 1.09
Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol Dial Transplant (2005) 1.06
Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol (2006) 1.03
Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int (2003) 0.99
Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy. Kidney Int (1995) 0.98
Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice. Kidney Int (2009) 0.97
Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis (1995) 0.96
Activation of Erk1/2 and Akt following unilateral ureteral obstruction. Kidney Int (2008) 0.96
Id-1 is induced in MDCK epithelial cells by activated Erk/MAPK pathway in response to expression of the Snail and E47 transcription factors. Exp Cell Res (2007) 0.95
Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int (2001) 0.95
Therapeutical relevance of MAP-kinase inhibitors in renal diseases: current knowledge and future clinical perspectives. Curr Med Chem (2008) 0.94
Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis. Exp Cell Res (2006) 0.90
Kindlin-2 regulates renal tubular cell plasticity by activation of Ras and its downstream signaling. Am J Physiol Renal Physiol (2013) 0.90
Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. Kidney Int (1995) 0.90
Inhibition of Ras/ERK1/2 signaling protects against postischemic renal injury. Am J Physiol Renal Physiol (2006) 0.89
Angiotensin-converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat. Am J Physiol Renal Physiol (2006) 0.89
Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptor. Trends Cardiovasc Med (2008) 0.87
Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. J Urol (2004) 0.87
H-Ras isoform modulates extracellular matrix synthesis, proliferation, and migration in fibroblasts. Am J Physiol Cell Physiol (2011) 0.87
Farnesyl transferase inhibitors induce neuroprotection by inhibiting Ha-Ras signalling pathway. Eur J Neurosci (2007) 0.87
Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction. J Urol (2006) 0.86
Comparative effects of ACE inhibition and angiotensin II receptor blockade in the prevention of renal damage. Kidney Int Suppl (2002) 0.86
Angiotensin AT1-receptor inhibition exacerbates renal injury resulting from partial unilateral ureteral obstruction in the neonatal rat. Am J Physiol Renal Physiol (2007) 0.85
Statins and progressive renal disease. Med Res Rev (2002) 0.84
Fibronectin is the major fibroblast chemoattractant in rabbit anti-glomerular basement membrane disease. Am J Pathol (1996) 0.81
Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat. Am J Nephrol (2011) 0.81
Atorvastatin protects renal function in the rat with acute unilateral ureteral obstruction. Urology (2010) 0.79
The small GTPase N-Ras regulates extracellular matrix synthesis, proliferation and migration in fibroblasts. Biochim Biophys Acta (2013) 0.78
Involvement of small Ras GTPases and their effectors in chronic renal disease. Cell Mol Life Sci (2008) 0.78
Effect of inhibition of farnesylation and geranylgeranylation on renal fibrogenesis in vitro. Nephron Exp Nephrol (2005) 0.77
Activation of small GTPase Ras and renal fibrosis. J Nephrol (2005) 0.77
Targeted genomic disruption of H-ras and N-ras has no effect on early renal changes after unilateral ureteral ligation. World J Urol (2009) 0.77
Renal angiotensin converting enzyme promotes renal damage during ureteral obstruction. J Urol (1998) 0.77
Antisense knockdown of Kras inhibits fibrosis in a rat model of unilateral ureteric obstruction. Am J Pathol (2011) 0.76
Farnesyltransferase as a target for anticancer drug design. Biopolymers (1997) 0.76
Evidence of a role for Ki-Ras in the stimulated proliferation of renal fibroblasts. J Am Soc Nephrol (1999) 0.76